| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/13/2003 | US20030032083 Biosynthesis of preferential peptide; obtain amino acid sequence, ligate protection group, deprotect peptide, recover peptide |
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032044 Detection of urogenital disorders in humans; obtain biological sample, monitor cytokine expression, compare to wild type control, evaluate for urogenital disorders |
| 02/13/2003 | US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030031673 Treatment and diagnosis of cancer |
| 02/13/2003 | US20030031672 Individualized anti-cancer antibodies |
| 02/13/2003 | US20030031670 Diagnosis and treatment of malignant neoplasms |
| 02/13/2003 | US20030031667 Human monoclonal antibodies to dendritic cells |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031654 Prohormone convertase transformed cells and polypeptide synthesis |
| 02/13/2003 | US20030031627 For diagnosis and therapy |
| 02/13/2003 | US20030031350 Methods for large scale protein matching |
| 02/13/2003 | US20030029086 Floral packaging material having great masters prints thereon |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | CA2454899A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 02/13/2003 | CA2454454A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453178A1 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283265A1 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283215A2 Secreted polypeptide and nucleic acids encoding it |
| 02/12/2003 | EP1283212A1 Methods for identifying compounds that bind to a target |
| 02/12/2003 | EP1283053A1 Inhibitors of HER3 activity |
| 02/12/2003 | EP1282721A1 Prion-free transgenic ungulates |
| 02/12/2003 | EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282433A1 Transgenically produced decorin |
| 02/12/2003 | EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 02/12/2003 | CN1396832A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 02/12/2003 | CN1396261A Human growth and differentiation factor 7 and its coding sequence preparing process and application |
| 02/12/2003 | CN1396182A Human monoclonal antibody of human endophloeodal growth factor receptor 2 protein and its preparing process |
| 02/12/2003 | CN1101472C Process for preparing recombination colbacillus periplams protein liquid |
| 02/12/2003 | CN1101471C Process for preparing active peptide of soybean protein |
| 02/12/2003 | CN1101403C Preparation of granulocyte colony stimulation factor |
| 02/11/2003 | WO2002014871A1 Method of detecting or assaying hbv |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518058 Method of preparing polypeptides in cell-free system and device for its realization |
| 02/11/2003 | US6518054 Genes encoding variants of metallo-endopeptidases that have been engineered to be resistant to prolonged boiling while having maintained their enzymatic performance at much lower temperatures. thermal stability of the metallo-endopeptidases |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518045 Feline cytokine protein |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518040 In vitro production of proteins by translation of mRNA immobilized on a solid surface |
| 02/11/2003 | US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/11/2003 | US6518016 Screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding |
| 02/11/2003 | US6517851 Reducing nematode infestation with fungi treated oil having nematicidal activity |
| 02/11/2003 | US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2 |
| 02/11/2003 | US6517830 In vivo gene delivery of nucleic acid sequences encoding the factor VIII protein to the liver endothelial sinusoidal cells; use in the gene therapy treatment of hemophilia A |
| 02/11/2003 | CA2231409C Antibodies specific for native prpsc |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
| 02/11/2003 | CA2152667C Bone resorption assay |
| 02/11/2003 | CA2142181C Androgen regulation with dna sequences of rat probasin gene |
| 02/11/2003 | CA2133843C Melanocyte stimulating hormone receptor and uses |
| 02/11/2003 | CA2101733C Enzymatic reverse hydrolysis of hydrophilic substrates-preparation of amphiphilic compounds |
| 02/11/2003 | CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region |
| 02/11/2003 | CA2068871C Non-glycosylated fgf-4 and compositions containing the same |
| 02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 02/08/2003 | CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives |
| 02/06/2003 | WO2003010539A1 Method and means for detecting alcohol consumption |
| 02/06/2003 | WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010307A1 Peptide synthase gene, peptide synthase and process for producing dipeptide |
| 02/06/2003 | WO2003010282A2 Interleukin-1 beta antibodies |
| 02/06/2003 | WO2003010204A1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 02/06/2003 | WO2003010202A1 Concatameric immunoadhesion |
| 02/06/2003 | WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 02/06/2003 | WO2003010196A2 Variants and exons of the glyt1 transporter |
| 02/06/2003 | WO2003010194A2 Meningococcus adhesins nada, app and orf 40 |
| 02/06/2003 | WO2003010189A1 Process for producing dipeptide, peptide synthase to be used therein and process for producing peptide synthase |
| 02/06/2003 | WO2003010188A1 Production of high molecular mass lectins |
| 02/06/2003 | WO2003010187A1 Process for producing dipeptide, l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase |
| 02/06/2003 | WO2003010186A2 Method for making acylated polypeptides |
| 02/06/2003 | WO2003010185A2 Method for making acylated polypeptides |
| 02/06/2003 | WO2003009858A1 Fermentation medium and method |
| 02/06/2003 | WO2003009817A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 02/06/2003 | WO2003009816A2 Facile detection of polycythemia vera |
| 02/06/2003 | WO2003009814A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 02/06/2003 | WO2002063005A3 Lipid-associated molecules |
| 02/06/2003 | WO2002059613A3 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |